MOPSY – Multidisciplinary Psychosocial Cancer Research Group
Anssi Auvinen – Cancer Epidemiology, Prostate Cancer Screening
G Steven Bova – PELICAN, Personalized Cancer Medicine
Kirsi Rautajoki – Cancer Regulation and Immunology
Mikko Hurme – Microbiology and Immunology
Vesa Hytönen – Protein Dynamics
Teemu Ihalainen – Cellular Biophysics
Arja Jukkola – Radiotherapy and oncology
Meenakshi Kandhavelu – Molecular Signaling Lab
Xin Lai – Lailab
Johanna Laukkarinen – Tampere Pancreas Group
Terho Lehtimäki – Clinical Chemistry
Matti Lehtinen – HPV Vaccination Research
Olli Lohi – Hematology and Oncology
Teemu Murtola – Pharmacoepidemiology and Chemoprevention of Urological Cancers
Matti Nykter – Computational Biology
Niku Oksala – Surgery (especially Vascular Surgery)
Seppo Parkkila – Anatomy and Tissue Biology
Ilkka Pietilä – QPro3 (MOPSY)
Pekka Ruusuvuori – Bioimage Informatics
Olli Silvennoinen – Medical Biochemistry
Alfonso Urbanucci – Genomic Regulation for Precision Cancer Medicine
Toni Seppälä – Precision Medicine in Abdominal Cancers
Tapio Visakorpi – Molecular Biology of Prostate Cancer
Minni Änkö – Functional RNAomics
Research centers
Prostate Cancer Research Center
Prostate Cancer Research Center (PCRC) is a multidisciplinary research center at the Tampere University. It combines basic sciences, epidemiology, computational biology, and clinical practice to find answers enabling better management of prostate cancer and to reduce the burden of prostate cancer on society.
More information:
Clinical Trial Units at TAMPERE UNIVERSITY HOSPITAL
FONK for adults:
FONK is a cancer medication research unit for adults that operates at the Tampere Univeristy Hospital. The objectives of the unit are to improve the research possibilities of new cancer medication and to introduce new medication to patient use as early as possible.
More information:
Cancer Medication Research (FONK) at Tays Cancer Centre, Tampere University Hospital
List of Clinical Trails at FONK
PeeTU for children:
Paediatric Clinical Trials Unit (PeeTU) operates at the Tampere Univeristy Hospital. It offers centralised clinical trial services (phase I-II) to children and adolescents in Finland. The major goal is to provide access to early phase clinical trials for children with relapsed or refractory cancers, but we also aim to find novel agents to treat various other conditions.
More information: